BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9476906)

  • 1. Platelet-activating factor plays a pivotal role in the induction of experimental lung injury.
    Miotla JM; Jeffery PK; Hellewell PG
    Am J Respir Cell Mol Biol; 1998 Feb; 18(2):197-204. PubMed ID: 9476906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin.
    Sanz MJ; Weg VB; Walsh DT; Williams TJ; Nourshargh S
    Br J Pharmacol; 1994 Oct; 113(2):513-21. PubMed ID: 7834203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of acute lung injury in mice by an inhibitor of phosphodiesterase type 4.
    Miotla JM; Teixeira MM; Hellewell PG
    Am J Respir Cell Mol Biol; 1998 Mar; 18(3):411-20. PubMed ID: 9490659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of platelet-activating factor (PAF) in platelet accumulation in rabbit skin: effect of the novel long-acting PAF antagonist, UK-74,505.
    Pons F; Rossi AG; Norman KE; Williams TJ; Nourshargh S
    Br J Pharmacol; 1993 May; 109(1):234-42. PubMed ID: 8495241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the reversed passive Arthus and local Shwartzman reactions of rabbit skin: effects of the long-acting PAF antagonist UK-74,505.
    Norman KE; Williams TJ; Rossi AG
    Br J Pharmacol; 1997 Apr; 120(7):1286-93. PubMed ID: 9105704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
    Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
    J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for the beta2 integrin CD11b in mediating experimental lung injury in mice.
    Miotla JM; Williams TJ; Hellewell PG; Jeffery PK
    Am J Respir Cell Mol Biol; 1996 Apr; 14(4):363-73. PubMed ID: 8600941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the platelet-activating factor (PAF) receptor during pulmonary infection with gram negative bacteria.
    Soares AC; Pinho VS; Souza DG; Shimizu T; Ishii S; Nicoli JR; Teixeira MM
    Br J Pharmacol; 2002 Nov; 137(5):621-8. PubMed ID: 12381675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primed neutrophils injure rat lung through a platelet-activating factor-dependent mechanism.
    Anderson BO; Poggetti RS; Shanley PF; Bensard DD; Pitman JM; Nelson DW; Whitman GJ; Banerjee A; Harken AH
    J Surg Res; 1991 May; 50(5):510-4. PubMed ID: 1710005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of complement in endotoxin/platelet-activating factor-induced lung injury.
    Rabinovici R; Yeh CG; Hillegass LM; Griswold DE; DiMartino MJ; Vernick J; Fong KL; Feuerstein G
    J Immunol; 1992 Sep; 149(5):1744-50. PubMed ID: 1324280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor mediates acid-induced lung injury in genetically engineered mice.
    Nagase T; Ishii S; Kume K; Uozumi N; Izumi T; Ouchi Y; Shimizu T
    J Clin Invest; 1999 Oct; 104(8):1071-6. PubMed ID: 10525045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotactic mediator requirements in lung injury following skin burns in rats.
    Piccolo MT; Wang Y; Sannomiya P; Piccolo NS; Piccolo MS; Hugli TE; Ward PA; Till GO
    Exp Mol Pathol; 1999 Aug; 66(3):220-6. PubMed ID: 10486240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor.
    Chang SW
    J Lab Clin Med; 1994 Jan; 123(1):65-72. PubMed ID: 8288963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary endothelial activation caused by extracellular histones contributes to neutrophil activation in acute respiratory distress syndrome.
    Zhang Y; Guan L; Yu J; Zhao Z; Mao L; Li S; Zhao J
    Respir Res; 2016 Nov; 17(1):155. PubMed ID: 27871277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAF and immune complex-induced injury.
    Warren JS; Johnson KJ; Ward PA
    J Lipid Mediat; 1990; 2 Suppl():S229-37. PubMed ID: 1966816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between interleukin-1 beta and platelet-activating factor in the pathogenesis of acute immune complex alveolitis in the rat.
    Warren JS
    Am J Pathol; 1992 Sep; 141(3):551-60. PubMed ID: 1519663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endotoxaemia in rats: role of NO, PAF and TXA2 in pulmonary neutrophil sequestration and hyperlactataemia.
    Olszanecki R; Chłopicki S
    J Physiol Pharmacol; 1999 Sep; 50(3):443-54. PubMed ID: 10574473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility to platelet-activating factor-induced airway hyperreactivity and hyperpermeability: interstrain variation and genetic control.
    Longphre M; Kleeberger SR
    Am J Respir Cell Mol Biol; 1995 Nov; 13(5):586-94. PubMed ID: 7576695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive effect of intravascular complement activation and brief episodes of hypoxia in producing increased permeability in the rabbit lung.
    Larsen GL; Webster RO; Worthen GS; Gumbay RS; Henson PM
    J Clin Invest; 1985 Mar; 75(3):902-10. PubMed ID: 3980730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment.
    Souza DG; Pinho V; Soares AC; Shimizu T; Ishii S; Teixeira MM
    Br J Pharmacol; 2003 Jun; 139(4):733-40. PubMed ID: 12812996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.